A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
Clinical trial NCT06773195 · RECRUITING
Trial details
- NCT number
- NCT06773195
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-07
- Primary completion
- 2028-01-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.